Breaking News

Thursday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Hot Stocks
Bionano Genomics announces publication on use of OGM to identify SVs » 08:03
01/20/22
01/20
08:03
01/20/22
08:03
BNGO

Bionano Genomics

$2.32 /

-0.03 (-1.28%)

Bionano Genomics…

Bionano Genomics announced the publication of a study that described the use of OGM to identify rare human genomic structural variants (SVs) as predisposition factors associated with severe COVID-19, highlighting the potential role of SVs in the pathogenesis of COVID-19 severity. The International COVID-19 Host Genome Structural Variation Consortium is a global open host genome structural variation consortium for the COVID-19 response. It is comprised of over 30 researchers from leading institutions who are using long-read molecule technologies, including OGM, to assess SVs in the human genome that could be contributing to COVID-19 susceptibility or progression. In this peer-reviewed study, published in the journal iScience, researchers performed OGM on samples from 52 severely ill COVID-19 patients to investigate SVs as decisive predisposition factors associated with COVID-19. They identified 7 SVs in 9 patients involving genes implicated in two key host-viral interaction pathways: innate immunity and inflammatory response, and viral replication and spread. The study authors reported that SVs in two genes, STK26 and DPP4, are the most intriguing candidates in these biological pathways. As the authors indicate, this is the first study to systematically assess the potential role of SVs in the pathogenesis of COVID-19 severity. These findings indicate that SVs can be a factor in COVID-19 severity and expand the research community's understanding of COVID-19 susceptibility and progression.

ShowHide Related Items >><<
BNGO Bionano Genomics
$2.32 /

-0.03 (-1.28%)

BNGO Bionano Genomics
$2.32 /

-0.03 (-1.28%)

12/27/21 Oppenheimer
Oppenheimer bullish on Bionano Genomics, sees potential Q4 upside
06/16/21 BTIG
Bionano Genomics initiated with a Buy at BTIG
02/08/21 Oppenheimer
Bionano Genomics price target raised to $15 from $1.50 at Oppenheimer
01/26/21 Ladenburg
Bionano Genomics price target raised to $14 from $1.25 at Ladenburg
BNGO Bionano Genomics
$2.32 /

-0.03 (-1.28%)

BNGO Bionano Genomics
$2.32 /

-0.03 (-1.28%)

BNGO Bionano Genomics
$2.32 /

-0.03 (-1.28%)

Wednesday
Hot Stocks
Bionano Genomics announces average daily attendance of 565 for 2022 Symposium » 08:04
01/19/22
01/19
08:04
01/19/22
08:04
BNGO

Bionano Genomics

$2.35 /

-0.2 (-7.86%)

Bionano Genomics…

Bionano Genomics announced the conclusion of Bionano's 2022 Symposium, with record daily attendance representing a 63% increase relative to last year's event. Bionano's premier scientific event showcasing OGM, Symposium was held January 10-13, 2022. Symposium had over 4,000 registrants from 82 countries and featured 31 oral presentations and 37 scientific posters from genomic scientists at leading institutions, including Brigham and Women's Hospital, MD Anderson Cancer Center, and Quest Diagnostics. During this four-day online event, presenters reported on their use of OGM and its utility for genetic disease and cancer applications.

ShowHide Related Items >><<
BNGO Bionano Genomics
$2.35 /

-0.2 (-7.86%)

BNGO Bionano Genomics
$2.35 /

-0.2 (-7.86%)

12/27/21 Oppenheimer
Oppenheimer bullish on Bionano Genomics, sees potential Q4 upside
06/16/21 BTIG
Bionano Genomics initiated with a Buy at BTIG
02/08/21 Oppenheimer
Bionano Genomics price target raised to $15 from $1.50 at Oppenheimer
01/26/21 Ladenburg
Bionano Genomics price target raised to $14 from $1.25 at Ladenburg
BNGO Bionano Genomics
$2.35 /

-0.2 (-7.86%)

  • 20
    Jan
BNGO Bionano Genomics
$2.35 /

-0.2 (-7.86%)

BNGO Bionano Genomics
$2.35 /

-0.2 (-7.86%)

Over a week ago
On The Fly
Wall Street in Fives - Must Read Lists for Wednesday » 16:31
01/12/22
01/12
16:31
01/12/22
16:31
BIIB

Biogen

$225.35 /

-16.06 (-6.65%)

, C

Citi

$67.28 /

+0.15 (+0.22%)

, FLMN

Falcon Minerals

$5.03 /

-0.42 (-7.71%)

, JOBS

51job

$50.00 /

+4.125 (+8.99%)

, MRNA

Moderna

$222.92 /

+1.53 (+0.69%)

, PYPL

PayPal

$187.24 /

-4.29 (-2.24%)

, SNOW

Snowflake

$307.15 /

+6.03 (+2.00%)

, DASH

DoorDash

$140.60 /

-3.14 (-2.18%)

, BZFD

BuzzFeed

$4.56 /

-0.01 (-0.22%)

, SHOP

Shopify

$1,168.73 /

+11.05 (+0.95%)

, SAN

Banco Santander

$3.59 /

-0.02 (-0.55%)

, DIDI

Didi

$4.96 /

+0.055 (+1.12%)

, AAPL

Apple

$175.55 /

+0.54 (+0.31%)

, TSLA

Tesla

$1,106.03 /

+41.96 (+3.94%)

, T

AT&T

$26.45 /

+0.11 (+0.42%)

, DISH

Dish

$36.38 /

+0.98 (+2.77%)

, OCGN

Ocugen

$4.19 /

+0.05 (+1.21%)

, PL

Planet Labs

$6.22 /

+0.585 (+10.38%)

, BBBY

Bed Bath & Beyond

$13.80 /

+0.67 (+5.10%)

, HYZN

Hyzon Motors

$6.06 /

-0.75 (-11.02%)

, JEF

Jefferies Financial Group

$37.59 /

-3.835 (-9.26%)

, WIT

Wipro

$8.70 /

-0.805 (-8.47%)

, DGX

Quest Diagnostics

$146.99 /

-10.69 (-6.78%)

, PHG

Philips

$33.08 /

-5.69 (-14.68%)

, ISRG

Intuitive Surgical

$322.90 /

-4.89 (-1.49%)

, BNGO

Bionano Genomics

$2.79 /

+0.045 (+1.64%)

, KLR

Kaleyra

$9.28 /

+0.24 (+2.65%)

Get caught up quickly on…

ShowHide Related Items >><<
WIT Wipro
$8.70 /

-0.805 (-8.47%)

TSLA Tesla
$1,106.03 /

+41.96 (+3.94%)

T AT&T
$26.45 /

+0.11 (+0.42%)

SNOW Snowflake
$307.15 /

+6.03 (+2.00%)

SHOP Shopify
$1,168.73 /

+11.05 (+0.95%)

SAN Banco Santander
$3.59 /

-0.02 (-0.55%)

PYPL PayPal
$187.24 /

-4.29 (-2.24%)

PL Planet Labs
$6.22 /

+0.585 (+10.38%)

PHG Philips
$33.08 /

-5.69 (-14.68%)

OCGN Ocugen
$4.19 /

+0.05 (+1.21%)

MRNA Moderna
$222.92 /

+1.53 (+0.69%)

KLR Kaleyra
$9.28 /

+0.24 (+2.65%)

JOBS 51job
$50.00 /

+4.125 (+8.99%)

JEF Jefferies Financial Group
$37.59 /

-3.835 (-9.26%)

ISRG Intuitive Surgical
$322.90 /

-4.89 (-1.49%)

HYZN Hyzon Motors
$6.06 /

-0.75 (-11.02%)

FLMN Falcon Minerals
$5.03 /

-0.42 (-7.71%)

DISH Dish
$36.38 /

+0.98 (+2.77%)

DIDI Didi
$4.96 /

+0.055 (+1.12%)

DGX Quest Diagnostics
$146.99 /

-10.69 (-6.78%)

DASH DoorDash
$140.60 /

-3.14 (-2.18%)

C Citi
$67.28 /

+0.15 (+0.22%)

BZFD BuzzFeed
$4.56 /

-0.01 (-0.22%)

BNGO Bionano Genomics
$2.79 /

+0.045 (+1.64%)

BIIB Biogen
$225.35 /

-16.06 (-6.65%)

BBBY Bed Bath & Beyond
$13.80 /

+0.67 (+5.10%)

AAPL Apple
$175.55 /

+0.54 (+0.31%)

BIIB Biogen
$225.35 /

-16.06 (-6.65%)

01/13/22 Guggenheim
Biogen downgraded to Neutral from Buy at Guggenheim
01/13/22 Guggenheim
Biogen downgraded to Neutral from Buy at Guggenheim
01/12/22 Stifel
Stifel says Biogen BAN2401 data the 'big 2022 event' after 'big blow' to Aduhelm
01/12/22 Wedbush
Biogen price target lowered to $195 from $249 at Wedbush
C Citi
$67.28 /

+0.15 (+0.22%)

01/12/22 JPMorgan
Citi 'continues to dismantle itself,' says JPMorgan
01/06/22 JPMorgan
Citi price target lowered to $76 from $80.50 at JPMorgan
01/03/22 Barclays
Citi price target lowered to $73 from $86 at Barclays
12/15/21 Odeon Capital
Citi upgraded to Buy from Hold at Odeon Capital
FLMN Falcon Minerals
$5.03 /

-0.42 (-7.71%)

01/12/22 Stifel
Falcon Minerals merger with Desert Peak 'transformative,' says Stifel
11/30/21 Wells Fargo
Falcon Minerals downgraded to Equal Weight on valuation at Wells Fargo
11/30/21 Wells Fargo
Falcon Minerals downgraded to Equal Weight from Overweight at Wells Fargo
10/13/21 Piper Sandler
Falcon Minerals price target raised to $6.50 from $5 at Piper Sandler
JOBS 51job
$50.00 /

+4.125 (+8.99%)

06/28/21 Citi
51job downgraded to Neutral from Buy at Citi
MRNA Moderna
$222.92 /

+1.53 (+0.69%)

01/06/22 Argus
Moderna price target lowered to $350 from $420 at Argus
01/05/22 Piper Sandler
Piper keeps $348 target on Moderna after Epstein-Barr vaccine trial starts
12/20/21 Piper Sandler
Piper keeps Overweight rating, $348 price target on Moderna after omicron data
12/16/21 Piper Sandler
Arcturus data shows 'legit player' in COVID vaccines, says Piper Sandler
PYPL PayPal
$187.24 /

-4.29 (-2.24%)

01/12/22 Jefferies
PayPal downgraded to Hold from Buy at Jefferies
01/11/22 Raymond James
PayPal price target lowered to $229 from $264 at Raymond James
01/10/22 Exane BNP Paribas
PayPal downgraded on share loss concerns at Exane BNP Paribas
01/10/22 Exane BNP Paribas
PayPal downgraded to Neutral from Outperform at Exane BNP Paribas
SNOW Snowflake
$307.15 /

+6.03 (+2.00%)

01/12/22 Barclays
Snowflake upgraded to Overweight on recent selloff at Barclays
01/12/22 Barclays
Snowflake upgraded to Overweight from Equal Weight at Barclays
01/06/22 Jefferies
Snowflake price target lowered to $330 from $360 at Jefferies
12/06/21 Credit Suisse
Snowflake price target raised to $465 from $455 at Credit Suisse
DASH DoorDash
$140.60 /

-3.14 (-2.18%)

01/11/22 Evercore ISI
Evercore upgrades DoorDash, adds to 'TAP Outperform' list
01/11/22 Evercore ISI
DoorDash upgraded to Outperform from In Line at Evercore ISI
12/20/21 Loop Capital
Marqeta initiated with a Hold at Loop Capital
12/15/21 JPMorgan
DoorDash price target lowered to $175 from $220 at JPMorgan
BZFD BuzzFeed
$4.56 /

-0.01 (-0.22%)

01/12/22 Craig-Hallum
Craig-Hallum bullish on BuzzFeed, initiates with a Buy
01/12/22 Craig-Hallum
BuzzFeed initiated with a Buy at Craig-Hallum
01/10/22 Cowen
BuzzFeed initiated with an Outperform at Cowen
SHOP Shopify
$1,168.73 /

+11.05 (+0.95%)

01/12/22 Stifel
Shopify price target lowered to $1,300 from $1,550 at Stifel
01/12/22 William Blair
William Blair upgrades Shopify on 'more reasonable' valuation post selloff
01/12/22 William Blair
Shopify upgraded to Outperform from Market Perform at William Blair
01/12/22 William Blair
Shopify upgraded to Outperform from Market Perform at William Blair
SAN Banco Santander
$3.59 /

-0.02 (-0.55%)

01/06/22 RBC Capital
Banco Santander downgraded to Sector Perform from Outperform at RBC Capital
12/08/21 Credit Suisse
Banco Santander downgraded to Neutral from Outperform at Credit Suisse
11/12/21 Morgan Stanley
Banco Santander downgraded to Equal Weight from Overweight at Morgan Stanley
10/28/21 JPMorgan
Banco Santander price target raised to EUR 3.60 from EUR 3.50 at JPMorgan
DIDI Didi
$4.96 /

+0.055 (+1.12%)

07/28/21 Alliance Global Partners
Alliance Global Partners bullish on Aurora Mobile despite regulatory changes
07/28/21 Alliance Global Partners
iClick Interactive price target lowered to $15 from $21 at Alliance Global
07/26/21 Atlantic Equities
Atlantic Equities downgrades DiDi to Neutral amid active investigations
07/26/21 Atlantic Equities
DiDi downgraded to Neutral from Overweight at Atlantic Equities
AAPL Apple
$175.55 /

+0.54 (+0.31%)

01/11/22 KeyBanc
Cirrus Logic price target raised to $120 from $105 at KeyBanc
01/11/22 Morgan Stanley
Amazon price target raised to $4,200 from $4,000 at Morgan Stanley
01/11/22 Bernstein
Apple price target raised to $170 from $132 at Bernstein
01/10/22 KeyBanc
Monthly Apple credit card suggests strong upcoming quarter, says KeyBanc
TSLA Tesla
$1,106.03 /

+41.96 (+3.94%)

01/12/22 New Street
New Street sees 50% upside in Tesla this year amid 'perfect storm'
01/11/22 Redburn
Redburn starts Lucid Group at Neutral on risks of competing against Tesla
01/10/22 Morgan Stanley
Tesla price target raised to $1,300 from $1,200 at Morgan Stanley
01/10/22 Goldman Sachs
Goldman ups Tesla price target, says best positioned in EVs
T AT&T
$26.45 /

+0.11 (+0.42%)

01/11/22 Citi
Citi adds Crown Castle, Switch to 'Positive Catalyst Watch List'
01/11/22 Citi
Citi adds AT&T to 'positive catalyst watch list,' keeps $29 target
01/07/22 Wells Fargo
Wells upgrades AT&T to neutral with downside risks 'more limited'
01/07/22 Wells Fargo
AT&T upgraded to Equal Weight from Underweight at Wells Fargo
DISH Dish
$36.38 /

+0.98 (+2.77%)

11/10/21 Deutsche Bank
Dish price target lowered to $71 from $77 at Deutsche Bank
09/17/21 Pivotal Research
Dish price target raised to $65 from $60 at Pivotal Research
08/12/21 Deutsche Bank
Dish price target raised to $77 from $68 at Deutsche Bank
08/03/21 Truist
SBA Communications price target raised to $400 from $335 at Truist
OCGN Ocugen
$4.19 /

+0.05 (+1.21%)

07/26/21 Noble Capital
Ocugen initiated with an Outperform at Noble Capital
07/06/21 Roth Capital
Covaxin data continue to meet FDA efficacy threshold, says Roth Capital
06/11/21
Fly Intel: Top five analyst downgrades
06/11/21 H.C. Wainwright
Ocugen price target lowered to $10 from $12 at H.C. Wainwright
PL Planet Labs
$6.22 /

+0.585 (+10.38%)

01/12/22 Goldman Sachs
Planet Labs initiated with a Buy at Goldman Sachs
01/07/22 Wedbush
Planet Labs initiated with an Outperform at Wedbush
01/07/22 Piper Sandler
Planet Labs initiated with an Overweight at Piper Sandler
09/27/21 Craig-Hallum
dMY Technology Group IV initiated with a Buy, $15 target at Craig-Hallum
BBBY Bed Bath & Beyond
$13.80 /

+0.67 (+5.10%)

01/11/22 Argus
Argus lowers EPS view on Bed Bath & Beyond
01/07/22 Loop Capital
Bed Bath & Beyond price target lowered to $10 from $14 at Loop Capital
01/07/22 B. Riley
Bed Bath & Beyond price target lowered to $19 from $28 at B. Riley
01/07/22 Baird
Bed Bath & Beyond price target lowered to $14 from $22 at Baird
HYZN Hyzon Motors
$6.06 /

-0.75 (-11.02%)

12/23/21 Canaccord
Canaccord starts Hyzon Motors at Buy with $12 price target
12/23/21 Canaccord
Hyzon Motors initiated with a Buy at Canaccord
10/19/21 Goldman Sachs
Hyzon Motors initiated with a Neutral at Goldman Sachs
09/09/21 JPMorgan
Hyzon Motors initiated with an Overweight at JPMorgan
JEF Jefferies Financial Group
$37.59 /

-3.835 (-9.26%)

01/03/22 Keefe Bruyette
Apollo long, Rocket short amid KBW's 13 best ideas for 2022
12/16/21 Morgan Stanley
Jefferies Financial Group initiated with an Equal Weight at Morgan Stanley
11/16/21 Keefe Bruyette
Jefferies downgraded to Market Perform on valuation at Keefe Bruyette
11/16/21 Keefe Bruyette
Jefferies Financial Group downgraded to Market Perform from Outperform at Keefe Bruyette
WIT Wipro
$8.70 /

-0.805 (-8.47%)

10/14/21 Morgan Stanley
Wipro upgraded to Equal Weight at Morgan Stanley on strong execution
10/14/21 Morgan Stanley
Wipro upgraded to Equal Weight from Underweight at Morgan Stanley
09/30/21 JPMorgan
Wipro upgraded to Neutral at JPMorgan on growth acceleration
09/30/21 JPMorgan
Wipro upgraded to Neutral from Underweight at JPMorgan
DGX Quest Diagnostics
$146.99 /

-10.69 (-6.78%)

01/13/22 Baird
Quest Diagnostics price target lowered to $162 from $173 at Baird
01/10/22 Deutsche Bank
Quest Diagnostics price target raised to $190 from $160 at Deutsche Bank
01/10/22 Citi
Quest Diagnostics transferred with Buy at Citi
01/05/22 Truist
Quest Diagnostics price target raised to $170 from $150 at Truist
PHG Philips
$33.08 /

-5.69 (-14.68%)

01/13/22 RBC Capital
ResMed price target raised to $234 from $227 at RBC Capital
01/12/22 Citi
Philips downgraded to Neutral at Citi after 'disappointing' pre-release
01/12/22 Citi
Philips downgraded to Neutral from Buy at Citi
01/10/22 Deutsche Bank
Philips price target lowered to EUR 35 from EUR 36 at Deutsche Bank
ISRG Intuitive Surgical
$322.90 /

-4.89 (-1.49%)

01/12/22 Piper Sandler
Intuitive Surgical 2022 procedure outlook 'touch light,' says Piper Sandler
01/10/22 BTIG
Intuitive Surgical upgraded to Buy from Neutral at BTIG
12/16/21
Fly Intel: Top five analyst upgrades
12/16/21 Goldman Sachs
Intuitive Surgical upgraded to Conviction Buy from Buy at Goldman Sachs
BNGO Bionano Genomics
$2.79 /

+0.045 (+1.64%)

12/27/21 Oppenheimer
Oppenheimer bullish on Bionano Genomics, sees potential Q4 upside
06/16/21 BTIG
Bionano Genomics initiated with a Buy at BTIG
02/08/21 Oppenheimer
Bionano Genomics price target raised to $15 from $1.50 at Oppenheimer
01/26/21 Ladenburg
Bionano Genomics price target raised to $14 from $1.25 at Ladenburg
KLR Kaleyra
$9.28 /

+0.24 (+2.65%)

08/10/21 Maxim
Kaleyra price target lowered to $37 from $42 at Maxim
06/15/21 Oppenheimer
Kaleyra price target raised to $20 from $12 at Oppenheimer
06/11/21 Northland
Kaleyra price target raised to $29 from $23 at Northland
03/19/21 Northland
Kaleyra on track for 21% growth in Q1, says Northland
WIT Wipro
$8.70 /

-0.805 (-8.47%)

TSLA Tesla
$1,106.03 /

+41.96 (+3.94%)

T AT&T
$26.45 /

+0.11 (+0.42%)

SNOW Snowflake
$307.15 /

+6.03 (+2.00%)

SHOP Shopify
$1,168.73 /

+11.05 (+0.95%)

PYPL PayPal
$187.24 /

-4.29 (-2.24%)

PL Planet Labs
$6.22 /

+0.585 (+10.38%)

PHG Philips
$33.08 /

-5.69 (-14.68%)

OCGN Ocugen
$4.19 /

+0.05 (+1.21%)

MRNA Moderna
$222.92 /

+1.53 (+0.69%)

KLR Kaleyra
$9.28 /

+0.24 (+2.65%)

JEF Jefferies Financial Group
$37.59 /

-3.835 (-9.26%)

ISRG Intuitive Surgical
$322.90 /

-4.89 (-1.49%)

HYZN Hyzon Motors
$6.06 /

-0.75 (-11.02%)

FLMN Falcon Minerals
$5.03 /

-0.42 (-7.71%)

DISH Dish
$36.38 /

+0.98 (+2.77%)

DIDI Didi
$4.96 /

+0.055 (+1.12%)

DGX Quest Diagnostics
$146.99 /

-10.69 (-6.78%)

DASH DoorDash
$140.60 /

-3.14 (-2.18%)

C Citi
$67.28 /

+0.15 (+0.22%)

BNGO Bionano Genomics
$2.79 /

+0.045 (+1.64%)

BIIB Biogen
$225.35 /

-16.06 (-6.65%)

BBBY Bed Bath & Beyond
$13.80 /

+0.67 (+5.10%)

AAPL Apple
$175.55 /

+0.54 (+0.31%)

  • 19
    Aug
  • 30
    Jun
  • 20
    May
  • 16
    Mar
  • 23
    Feb
  • 20
    Jan
TSLA Tesla
$1,106.03 /

+41.96 (+3.94%)

T AT&T
$26.45 /

+0.11 (+0.42%)

SHOP Shopify
$1,168.73 /

+11.05 (+0.95%)

SAN Banco Santander
$3.59 /

-0.02 (-0.55%)

PYPL PayPal
$187.24 /

-4.29 (-2.24%)

PHG Philips
$33.08 /

-5.69 (-14.68%)

OCGN Ocugen
$4.19 /

+0.05 (+1.21%)

MRNA Moderna
$222.92 /

+1.53 (+0.69%)

JOBS 51job
$50.00 /

+4.125 (+8.99%)

JEF Jefferies Financial Group
$37.59 /

-3.835 (-9.26%)

HYZN Hyzon Motors
$6.06 /

-0.75 (-11.02%)

DISH Dish
$36.38 /

+0.98 (+2.77%)

DIDI Didi
$4.96 /

+0.055 (+1.12%)

DGX Quest Diagnostics
$146.99 /

-10.69 (-6.78%)

DASH DoorDash
$140.60 /

-3.14 (-2.18%)

C Citi
$67.28 /

+0.15 (+0.22%)

BIIB Biogen
$225.35 /

-16.06 (-6.65%)

BBBY Bed Bath & Beyond
$13.80 /

+0.67 (+5.10%)

AAPL Apple
$175.55 /

+0.54 (+0.31%)

WIT Wipro
$8.70 /

-0.805 (-8.47%)

TSLA Tesla
$1,106.03 /

+41.96 (+3.94%)

T AT&T
$26.45 /

+0.11 (+0.42%)

SNOW Snowflake
$307.15 /

+6.03 (+2.00%)

SHOP Shopify
$1,168.73 /

+11.05 (+0.95%)

PYPL PayPal
$187.24 /

-4.29 (-2.24%)

PL Planet Labs
$6.22 /

+0.585 (+10.38%)

PHG Philips
$33.08 /

-5.69 (-14.68%)

MRNA Moderna
$222.92 /

+1.53 (+0.69%)

JOBS 51job
$50.00 /

+4.125 (+8.99%)

JEF Jefferies Financial Group
$37.59 /

-3.835 (-9.26%)

ISRG Intuitive Surgical
$322.90 /

-4.89 (-1.49%)

HYZN Hyzon Motors
$6.06 /

-0.75 (-11.02%)

DISH Dish
$36.38 /

+0.98 (+2.77%)

DIDI Didi
$4.96 /

+0.055 (+1.12%)

DGX Quest Diagnostics
$146.99 /

-10.69 (-6.78%)

DASH DoorDash
$140.60 /

-3.14 (-2.18%)

C Citi
$67.28 /

+0.15 (+0.22%)

BZFD BuzzFeed
$4.56 /

-0.01 (-0.22%)

BIIB Biogen
$225.35 /

-16.06 (-6.65%)

BBBY Bed Bath & Beyond
$13.80 /

+0.67 (+5.10%)

AAPL Apple
$175.55 /

+0.54 (+0.31%)

TSLA Tesla
$1,106.03 /

+41.96 (+3.94%)

T AT&T
$26.45 /

+0.11 (+0.42%)

SNOW Snowflake
$307.15 /

+6.03 (+2.00%)

SHOP Shopify
$1,168.73 /

+11.05 (+0.95%)

PYPL PayPal
$187.24 /

-4.29 (-2.24%)

PL Planet Labs
$6.22 /

+0.585 (+10.38%)

OCGN Ocugen
$4.19 /

+0.05 (+1.21%)

MRNA Moderna
$222.92 /

+1.53 (+0.69%)

JEF Jefferies Financial Group
$37.59 /

-3.835 (-9.26%)

ISRG Intuitive Surgical
$322.90 /

-4.89 (-1.49%)

HYZN Hyzon Motors
$6.06 /

-0.75 (-11.02%)

DISH Dish
$36.38 /

+0.98 (+2.77%)

DIDI Didi
$4.96 /

+0.055 (+1.12%)

DGX Quest Diagnostics
$146.99 /

-10.69 (-6.78%)

DASH DoorDash
$140.60 /

-3.14 (-2.18%)

C Citi
$67.28 /

+0.15 (+0.22%)

BZFD BuzzFeed
$4.56 /

-0.01 (-0.22%)

BNGO Bionano Genomics
$2.79 /

+0.045 (+1.64%)

BIIB Biogen
$225.35 /

-16.06 (-6.65%)

BBBY Bed Bath & Beyond
$13.80 /

+0.67 (+5.10%)

AAPL Apple
$175.55 /

+0.54 (+0.31%)

AAPL Apple
$175.55 /

+0.54 (+0.31%)

On The Fly
Wall Street in Fives - Must Read Lists at Midday » 12:14
01/12/22
01/12
12:14
01/12/22
12:14
BIIB

Biogen

$222.00 /

-19.41 (-8.04%)

, C

Citi

$67.27 /

+0.14 (+0.21%)

, FLMN

Falcon Minerals

$4.85 /

-0.595 (-10.93%)

, JOBS

51job

$51.55 /

+5.675 (+12.37%)

, T

AT&T

$26.48 /

+0.14 (+0.53%)

, DISH

Dish

$36.98 /

+1.58 (+4.46%)

, SAN

Banco Santander

$3.59 /

-0.02 (-0.55%)

, DIDI

Didi

$4.99 /

+0.085 (+1.73%)

, AAPL

Apple

$175.80 /

+0.79 (+0.45%)

, PRDS

Pardes Biosciences

$14.34 /

-0.3 (-2.05%)

, TSLA

Tesla

$1,092.01 /

+27.94 (+2.63%)

, OCGN

Ocugen

$4.26 /

+0.115 (+2.78%)

, PL

Planet Labs

$6.56 /

+0.925 (+16.42%)

, BBBY

Bed Bath & Beyond

$13.53 /

+0.4 (+3.05%)

, HYZN

Hyzon Motors

$6.17 /

-0.635 (-9.33%)

, JEF

Jefferies Financial Group

$36.87 /

-4.55 (-10.99%)

, WIT

Wipro

$8.70 /

-0.81 (-8.52%)

, DGX

Quest Diagnostics

$148.72 /

-8.96 (-5.68%)

, PHG

Philips

$32.78 /

-5.99 (-15.45%)

, ISRG

Intuitive Surgical

$322.00 /

-5.79 (-1.77%)

, BNGO

Bionano Genomics

$2.77 /

+0.02 (+0.73%)

, KLR

Kaleyra

$9.14 /

+0.1 (+1.11%)

, PYPL

PayPal

$187.44 /

-4.09 (-2.14%)

, SNOW

Snowflake

$308.30 /

+7.18 (+2.38%)

, DASH

DoorDash

$143.89 /

+0.15 (+0.10%)

, BZFD

BuzzFeed

$4.57 /

+ (+0.00%)

, SHOP

Shopify

$1,168.88 /

+11.2 (+0.97%)

Get caught up quickly on…

ShowHide Related Items >><<
WIT Wipro
$8.70 /

-0.81 (-8.52%)

TSLA Tesla
$1,092.01 /

+27.94 (+2.63%)

T AT&T
$26.48 /

+0.14 (+0.53%)

SNOW Snowflake
$308.30 /

+7.18 (+2.38%)

SHOP Shopify
$1,168.88 /

+11.2 (+0.97%)

SAN Banco Santander
$3.59 /

-0.02 (-0.55%)

PYPL PayPal
$187.44 /

-4.09 (-2.14%)

PRDS Pardes Biosciences
$14.34 /

-0.3 (-2.05%)

PL Planet Labs
$6.56 /

+0.925 (+16.42%)

PHG Philips
$32.78 /

-5.99 (-15.45%)

OCGN Ocugen
$4.26 /

+0.115 (+2.78%)

KLR Kaleyra
$9.14 /

+0.1 (+1.11%)

JOBS 51job
$51.55 /

+5.675 (+12.37%)

JEF Jefferies Financial Group
$36.87 /

-4.55 (-10.99%)

ISRG Intuitive Surgical
$322.00 /

-5.79 (-1.77%)

HYZN Hyzon Motors
$6.17 /

-0.635 (-9.33%)

FLMN Falcon Minerals
$4.85 /

-0.595 (-10.93%)

DISH Dish
$36.98 /

+1.58 (+4.46%)

DIDI Didi
$4.99 /

+0.085 (+1.73%)

DGX Quest Diagnostics
$148.72 /

-8.96 (-5.68%)

DASH DoorDash
$143.89 /

+0.15 (+0.10%)

C Citi
$67.27 /

+0.14 (+0.21%)

BZFD BuzzFeed
$4.57 /

+ (+0.00%)

BNGO Bionano Genomics
$2.77 /

+0.02 (+0.73%)

BIIB Biogen
$222.00 /

-19.41 (-8.04%)

BBBY Bed Bath & Beyond
$13.53 /

+0.4 (+3.05%)

AAPL Apple
$175.80 /

+0.79 (+0.45%)

BIIB Biogen
$222.00 /

-19.41 (-8.04%)

01/12/22 Stifel
Stifel says Biogen BAN2401 data the 'big 2022 event' after 'big blow' to Aduhelm
01/12/22 Wedbush
Biogen price target lowered to $195 from $249 at Wedbush
01/12/22 Cantor Fitzgerald
Biogen's peak sales for Aduhelm 'at risk,' says Cantor Fitzgerald
01/12/22 Needham
Biogen price target lowered to $292 from $328 at Needham
C Citi
$67.27 /

+0.14 (+0.21%)

01/12/22 JPMorgan
Citi 'continues to dismantle itself,' says JPMorgan
01/06/22 JPMorgan
Citi price target lowered to $76 from $80.50 at JPMorgan
01/03/22 Barclays
Citi price target lowered to $73 from $86 at Barclays
12/15/21 Odeon Capital
Citi upgraded to Buy from Hold at Odeon Capital
FLMN Falcon Minerals
$4.85 /

-0.595 (-10.93%)

01/12/22 Stifel
Falcon Minerals merger with Desert Peak 'transformative,' says Stifel
11/30/21 Wells Fargo
Falcon Minerals downgraded to Equal Weight on valuation at Wells Fargo
11/30/21 Wells Fargo
Falcon Minerals downgraded to Equal Weight from Overweight at Wells Fargo
10/13/21 Piper Sandler
Falcon Minerals price target raised to $6.50 from $5 at Piper Sandler
JOBS 51job
$51.55 /

+5.675 (+12.37%)

06/28/21 Citi
51job downgraded to Neutral from Buy at Citi
T AT&T
$26.48 /

+0.14 (+0.53%)

01/11/22 Citi
Citi adds Crown Castle, Switch to 'Positive Catalyst Watch List'
01/11/22 Citi
Citi adds AT&T to 'positive catalyst watch list,' keeps $29 target
01/07/22 Wells Fargo
Wells upgrades AT&T to neutral with downside risks 'more limited'
01/07/22 Wells Fargo
AT&T upgraded to Equal Weight from Underweight at Wells Fargo
DISH Dish
$36.98 /

+1.58 (+4.46%)

11/10/21 Deutsche Bank
Dish price target lowered to $71 from $77 at Deutsche Bank
09/17/21 Pivotal Research
Dish price target raised to $65 from $60 at Pivotal Research
08/12/21 Deutsche Bank
Dish price target raised to $77 from $68 at Deutsche Bank
08/03/21 Truist
SBA Communications price target raised to $400 from $335 at Truist
SAN Banco Santander
$3.59 /

-0.02 (-0.55%)

01/06/22 RBC Capital
Banco Santander downgraded to Sector Perform from Outperform at RBC Capital
12/08/21 Credit Suisse
Banco Santander downgraded to Neutral from Outperform at Credit Suisse
11/12/21 Morgan Stanley
Banco Santander downgraded to Equal Weight from Overweight at Morgan Stanley
10/28/21 JPMorgan
Banco Santander price target raised to EUR 3.60 from EUR 3.50 at JPMorgan
DIDI Didi
$4.99 /

+0.085 (+1.73%)

07/28/21 Alliance Global Partners
Alliance Global Partners bullish on Aurora Mobile despite regulatory changes
07/28/21 Alliance Global Partners
iClick Interactive price target lowered to $15 from $21 at Alliance Global
07/26/21 Atlantic Equities
Atlantic Equities downgrades DiDi to Neutral amid active investigations
07/26/21 Atlantic Equities
DiDi downgraded to Neutral from Overweight at Atlantic Equities
AAPL Apple
$175.80 /

+0.79 (+0.45%)

01/11/22 KeyBanc
Cirrus Logic price target raised to $120 from $105 at KeyBanc
01/11/22 Morgan Stanley
Amazon price target raised to $4,200 from $4,000 at Morgan Stanley
01/11/22 Bernstein
Apple price target raised to $170 from $132 at Bernstein
01/10/22 KeyBanc
Monthly Apple credit card suggests strong upcoming quarter, says KeyBanc
PRDS Pardes Biosciences
$14.34 /

-0.3 (-2.05%)

TSLA Tesla
$1,092.01 /

+27.94 (+2.63%)

01/12/22 New Street
New Street sees 50% upside in Tesla this year amid 'perfect storm'
01/11/22 Redburn
Redburn starts Lucid Group at Neutral on risks of competing against Tesla
01/10/22 Morgan Stanley
Tesla price target raised to $1,300 from $1,200 at Morgan Stanley
01/10/22 Goldman Sachs
Goldman ups Tesla price target, says best positioned in EVs
OCGN Ocugen
$4.26 /

+0.115 (+2.78%)

07/26/21 Noble Capital
Ocugen initiated with an Outperform at Noble Capital
07/06/21 Roth Capital
Covaxin data continue to meet FDA efficacy threshold, says Roth Capital
06/11/21
Fly Intel: Top five analyst downgrades
06/11/21 H.C. Wainwright
Ocugen price target lowered to $10 from $12 at H.C. Wainwright
PL Planet Labs
$6.56 /

+0.925 (+16.42%)

01/12/22 Goldman Sachs
Planet Labs initiated with a Buy at Goldman Sachs
01/07/22 Wedbush
Planet Labs initiated with an Outperform at Wedbush
01/07/22 Piper Sandler
Planet Labs initiated with an Overweight at Piper Sandler
09/27/21 Craig-Hallum
dMY Technology Group IV initiated with a Buy, $15 target at Craig-Hallum
BBBY Bed Bath & Beyond
$13.53 /

+0.4 (+3.05%)

01/11/22 Argus
Argus lowers EPS view on Bed Bath & Beyond
01/07/22 Loop Capital
Bed Bath & Beyond price target lowered to $10 from $14 at Loop Capital
01/07/22 B. Riley
Bed Bath & Beyond price target lowered to $19 from $28 at B. Riley
01/07/22 Baird
Bed Bath & Beyond price target lowered to $14 from $22 at Baird
HYZN Hyzon Motors
$6.17 /

-0.635 (-9.33%)

12/23/21 Canaccord
Canaccord starts Hyzon Motors at Buy with $12 price target
12/23/21 Canaccord
Hyzon Motors initiated with a Buy at Canaccord
10/19/21 Goldman Sachs
Hyzon Motors initiated with a Neutral at Goldman Sachs
09/09/21 JPMorgan
Hyzon Motors initiated with an Overweight at JPMorgan
JEF Jefferies Financial Group
$36.87 /

-4.55 (-10.99%)

01/03/22 Keefe Bruyette
Apollo long, Rocket short amid KBW's 13 best ideas for 2022
12/16/21 Morgan Stanley
Jefferies Financial Group initiated with an Equal Weight at Morgan Stanley
11/16/21 Keefe Bruyette
Jefferies downgraded to Market Perform on valuation at Keefe Bruyette
11/16/21 Keefe Bruyette
Jefferies Financial Group downgraded to Market Perform from Outperform at Keefe Bruyette
WIT Wipro
$8.70 /

-0.81 (-8.52%)

10/14/21 Morgan Stanley
Wipro upgraded to Equal Weight at Morgan Stanley on strong execution
10/14/21 Morgan Stanley
Wipro upgraded to Equal Weight from Underweight at Morgan Stanley
09/30/21 JPMorgan
Wipro upgraded to Neutral at JPMorgan on growth acceleration
09/30/21 JPMorgan
Wipro upgraded to Neutral from Underweight at JPMorgan
DGX Quest Diagnostics
$148.72 /

-8.96 (-5.68%)

01/10/22 Deutsche Bank
Quest Diagnostics price target raised to $190 from $160 at Deutsche Bank
01/10/22 Citi
Quest Diagnostics transferred with Buy at Citi
01/05/22 Truist
Quest Diagnostics price target raised to $170 from $150 at Truist
12/16/21 Mizuho
Quest Diagnostics price target raised to $185 from $166 at Mizuho
PHG Philips
$32.78 /

-5.99 (-15.45%)

01/12/22 Citi
Philips downgraded to Neutral at Citi after 'disappointing' pre-release
01/12/22 Citi
Philips downgraded to Neutral from Buy at Citi
01/10/22 Deutsche Bank
Philips price target lowered to EUR 35 from EUR 36 at Deutsche Bank
12/17/21 Barclays
Philips price target lowered to EUR 51.50 from EUR 52 at Barclays
ISRG Intuitive Surgical
$322.00 /

-5.79 (-1.77%)

01/12/22 Piper Sandler
Intuitive Surgical 2022 procedure outlook 'touch light,' says Piper Sandler
01/10/22 BTIG
Intuitive Surgical upgraded to Buy from Neutral at BTIG
12/16/21
Fly Intel: Top five analyst upgrades
12/16/21 Goldman Sachs
Intuitive Surgical upgraded to Conviction Buy from Buy at Goldman Sachs
BNGO Bionano Genomics
$2.77 /

+0.02 (+0.73%)

12/27/21 Oppenheimer
Oppenheimer bullish on Bionano Genomics, sees potential Q4 upside
06/16/21 BTIG
Bionano Genomics initiated with a Buy at BTIG
02/08/21 Oppenheimer
Bionano Genomics price target raised to $15 from $1.50 at Oppenheimer
01/26/21 Ladenburg
Bionano Genomics price target raised to $14 from $1.25 at Ladenburg
KLR Kaleyra
$9.14 /

+0.1 (+1.11%)

08/10/21 Maxim
Kaleyra price target lowered to $37 from $42 at Maxim
06/15/21 Oppenheimer
Kaleyra price target raised to $20 from $12 at Oppenheimer
06/11/21 Northland
Kaleyra price target raised to $29 from $23 at Northland
03/19/21 Northland
Kaleyra on track for 21% growth in Q1, says Northland
PYPL PayPal
$187.44 /

-4.09 (-2.14%)

01/12/22 Jefferies
PayPal downgraded to Hold from Buy at Jefferies
01/11/22 Raymond James
PayPal price target lowered to $229 from $264 at Raymond James
01/10/22 Exane BNP Paribas
PayPal downgraded on share loss concerns at Exane BNP Paribas
01/10/22 Exane BNP Paribas
PayPal downgraded to Neutral from Outperform at Exane BNP Paribas
SNOW Snowflake
$308.30 /

+7.18 (+2.38%)

01/12/22 Barclays
Snowflake upgraded to Overweight on recent selloff at Barclays
01/12/22 Barclays
Snowflake upgraded to Overweight from Equal Weight at Barclays
01/06/22 Jefferies
Snowflake price target lowered to $330 from $360 at Jefferies
12/06/21 Credit Suisse
Snowflake price target raised to $465 from $455 at Credit Suisse
DASH DoorDash
$143.89 /

+0.15 (+0.10%)

01/11/22 Evercore ISI
Evercore upgrades DoorDash, adds to 'TAP Outperform' list
01/11/22 Evercore ISI
DoorDash upgraded to Outperform from In Line at Evercore ISI
12/20/21 Loop Capital
Marqeta initiated with a Hold at Loop Capital
12/15/21 JPMorgan
DoorDash price target lowered to $175 from $220 at JPMorgan
BZFD BuzzFeed
$4.57 /

+ (+0.00%)

01/12/22 Craig-Hallum
Craig-Hallum bullish on BuzzFeed, initiates with a Buy
01/12/22 Craig-Hallum
BuzzFeed initiated with a Buy at Craig-Hallum
01/10/22 Cowen
BuzzFeed initiated with an Outperform at Cowen
SHOP Shopify
$1,168.88 /

+11.2 (+0.97%)

01/12/22 Stifel
Shopify price target lowered to $1,300 from $1,550 at Stifel
01/12/22 William Blair
William Blair upgrades Shopify on 'more reasonable' valuation post selloff
01/12/22 William Blair
Shopify upgraded to Outperform from Market Perform at William Blair
01/12/22 William Blair
Shopify upgraded to Outperform from Market Perform at William Blair
WIT Wipro
$8.70 /

-0.81 (-8.52%)

TSLA Tesla
$1,092.01 /

+27.94 (+2.63%)

T AT&T
$26.48 /

+0.14 (+0.53%)

SNOW Snowflake
$308.30 /

+7.18 (+2.38%)

SHOP Shopify
$1,168.88 /

+11.2 (+0.97%)

PYPL PayPal
$187.44 /

-4.09 (-2.14%)

PL Planet Labs
$6.56 /

+0.925 (+16.42%)

PHG Philips
$32.78 /

-5.99 (-15.45%)

OCGN Ocugen
$4.26 /

+0.115 (+2.78%)

KLR Kaleyra
$9.14 /

+0.1 (+1.11%)

JEF Jefferies Financial Group
$36.87 /

-4.55 (-10.99%)

ISRG Intuitive Surgical
$322.00 /

-5.79 (-1.77%)

HYZN Hyzon Motors
$6.17 /

-0.635 (-9.33%)

FLMN Falcon Minerals
$4.85 /

-0.595 (-10.93%)

DISH Dish
$36.98 /

+1.58 (+4.46%)

DIDI Didi
$4.99 /

+0.085 (+1.73%)

DGX Quest Diagnostics
$148.72 /

-8.96 (-5.68%)

DASH DoorDash
$143.89 /

+0.15 (+0.10%)

C Citi
$67.27 /

+0.14 (+0.21%)

BNGO Bionano Genomics
$2.77 /

+0.02 (+0.73%)

BIIB Biogen
$222.00 /

-19.41 (-8.04%)

BBBY Bed Bath & Beyond
$13.53 /

+0.4 (+3.05%)

AAPL Apple
$175.80 /

+0.79 (+0.45%)

  • 19
    Aug
  • 30
    Jun
  • 20
    May
  • 16
    Mar
  • 23
    Feb
  • 20
    Jan
TSLA Tesla
$1,092.01 /

+27.94 (+2.63%)

T AT&T
$26.48 /

+0.14 (+0.53%)

SHOP Shopify
$1,168.88 /

+11.2 (+0.97%)

SAN Banco Santander
$3.59 /

-0.02 (-0.55%)

PYPL PayPal
$187.44 /

-4.09 (-2.14%)

PRDS Pardes Biosciences
$14.34 /

-0.3 (-2.05%)

PHG Philips
$32.78 /

-5.99 (-15.45%)

OCGN Ocugen
$4.26 /

+0.115 (+2.78%)

JOBS 51job
$51.55 /

+5.675 (+12.37%)

JEF Jefferies Financial Group
$36.87 /

-4.55 (-10.99%)

HYZN Hyzon Motors
$6.17 /

-0.635 (-9.33%)

DISH Dish
$36.98 /

+1.58 (+4.46%)

DIDI Didi
$4.99 /

+0.085 (+1.73%)

DGX Quest Diagnostics
$148.72 /

-8.96 (-5.68%)

DASH DoorDash
$143.89 /

+0.15 (+0.10%)

C Citi
$67.27 /

+0.14 (+0.21%)

BIIB Biogen
$222.00 /

-19.41 (-8.04%)

BBBY Bed Bath & Beyond
$13.53 /

+0.4 (+3.05%)

AAPL Apple
$175.80 /

+0.79 (+0.45%)

WIT Wipro
$8.70 /

-0.81 (-8.52%)

TSLA Tesla
$1,092.01 /

+27.94 (+2.63%)

T AT&T
$26.48 /

+0.14 (+0.53%)

SNOW Snowflake
$308.30 /

+7.18 (+2.38%)

SHOP Shopify
$1,168.88 /

+11.2 (+0.97%)

PYPL PayPal
$187.44 /

-4.09 (-2.14%)

PL Planet Labs
$6.56 /

+0.925 (+16.42%)

PHG Philips
$32.78 /

-5.99 (-15.45%)

JOBS 51job
$51.55 /

+5.675 (+12.37%)

JEF Jefferies Financial Group
$36.87 /

-4.55 (-10.99%)

ISRG Intuitive Surgical
$322.00 /

-5.79 (-1.77%)

HYZN Hyzon Motors
$6.17 /

-0.635 (-9.33%)

DISH Dish
$36.98 /

+1.58 (+4.46%)

DIDI Didi
$4.99 /

+0.085 (+1.73%)

DGX Quest Diagnostics
$148.72 /

-8.96 (-5.68%)

DASH DoorDash
$143.89 /

+0.15 (+0.10%)

C Citi
$67.27 /

+0.14 (+0.21%)

BZFD BuzzFeed
$4.57 /

+ (+0.00%)

BIIB Biogen
$222.00 /

-19.41 (-8.04%)

BBBY Bed Bath & Beyond
$13.53 /

+0.4 (+3.05%)

AAPL Apple
$175.80 /

+0.79 (+0.45%)

TSLA Tesla
$1,092.01 /

+27.94 (+2.63%)

T AT&T
$26.48 /

+0.14 (+0.53%)

SNOW Snowflake
$308.30 /

+7.18 (+2.38%)

SHOP Shopify
$1,168.88 /

+11.2 (+0.97%)

PYPL PayPal
$187.44 /

-4.09 (-2.14%)

PL Planet Labs
$6.56 /

+0.925 (+16.42%)

OCGN Ocugen
$4.26 /

+0.115 (+2.78%)

JEF Jefferies Financial Group
$36.87 /

-4.55 (-10.99%)

ISRG Intuitive Surgical
$322.00 /

-5.79 (-1.77%)

HYZN Hyzon Motors
$6.17 /

-0.635 (-9.33%)

DISH Dish
$36.98 /

+1.58 (+4.46%)

DIDI Didi
$4.99 /

+0.085 (+1.73%)

DGX Quest Diagnostics
$148.72 /

-8.96 (-5.68%)

DASH DoorDash
$143.89 /

+0.15 (+0.10%)

C Citi
$67.27 /

+0.14 (+0.21%)

BZFD BuzzFeed
$4.57 /

+ (+0.00%)

BNGO Bionano Genomics
$2.77 /

+0.02 (+0.73%)

BIIB Biogen
$222.00 /

-19.41 (-8.04%)

BBBY Bed Bath & Beyond
$13.53 /

+0.4 (+3.05%)

AAPL Apple
$175.80 /

+0.79 (+0.45%)

AAPL Apple
$175.80 /

+0.79 (+0.45%)

Earnings
Bionano Genomics sees 2021 revenue $17.5M-$17.9M, consensus $17.13M » 08:14
01/12/22
01/12
08:14
01/12/22
08:14
BNGO

Bionano Genomics

$2.75 /

+0.03 (+1.10%)

"We ended the year…

"We ended the year with a lot of momentum across the business and have achieved or exceeded all of the milestones we set out at the beginning of 2021," commented Erik Holmlin, PhD, President and CEO of Bionano. "The integration of BioDiscovery is going well and the results from our first interim readout from our postnatal clinical trial exceeded our expectations. Additionally, there is a lot of excitement around our 2022 Symposium, which began earlier this week."

ShowHide Related Items >><<
BNGO Bionano Genomics
$2.75 /

+0.03 (+1.10%)

BNGO Bionano Genomics
$2.75 /

+0.03 (+1.10%)

12/27/21 Oppenheimer
Oppenheimer bullish on Bionano Genomics, sees potential Q4 upside
06/16/21 BTIG
Bionano Genomics initiated with a Buy at BTIG
02/08/21 Oppenheimer
Bionano Genomics price target raised to $15 from $1.50 at Oppenheimer
01/26/21 Ladenburg
Bionano Genomics price target raised to $14 from $1.25 at Ladenburg
BNGO Bionano Genomics
$2.75 /

+0.03 (+1.10%)

  • 20
    Jan
BNGO Bionano Genomics
$2.75 /

+0.03 (+1.10%)

Earnings
Bionano Genomics sees Q4 revenue $5.8M-$6.2M, consensus $5.44M » 08:13
01/12/22
01/12
08:13
01/12/22
08:13
BNGO

Bionano Genomics

$2.75 /

+0.03 (+1.10%)

Bionano also reported a…

Bionano also reported a record net increase in the installed base of 23 Saphyr systems in the fourth quarter of 2021, bringing the year-end total to 164, representing a 69% increase over the 97 installed systems reported at the end of 2020 and exceeding our goal of 150 systems by the end of 2021.

ShowHide Related Items >><<
BNGO Bionano Genomics
$2.75 /

+0.03 (+1.10%)

BNGO Bionano Genomics
$2.75 /

+0.03 (+1.10%)

12/27/21 Oppenheimer
Oppenheimer bullish on Bionano Genomics, sees potential Q4 upside
06/16/21 BTIG
Bionano Genomics initiated with a Buy at BTIG
02/08/21 Oppenheimer
Bionano Genomics price target raised to $15 from $1.50 at Oppenheimer
01/26/21 Ladenburg
Bionano Genomics price target raised to $14 from $1.25 at Ladenburg
BNGO Bionano Genomics
$2.75 /

+0.03 (+1.10%)

  • 20
    Jan
BNGO Bionano Genomics
$2.75 /

+0.03 (+1.10%)

Hot Stocks
Bionano Genomics announces publication of interim readout from trial on OGM » 08:58
01/10/22
01/10
08:58
01/10/22
08:58
BNGO

Bionano Genomics

$2.73 /

-0.03 (-1.09%)

Bionano Genomics…

Bionano Genomics announced the publication of the first readout from the ongoing clinical trial designed to support establishing optical genome mapping, OGM, as part of standard of care, SOC, in diagnosis of genetic disease for postnatal patients. This publication reports on the postnatal genetic disease diagnostic arm of Bionano's study to evaluate OGM as an alternative to SOC workflows in four key clinical areas: prenatal and postnatal genetic diseases, hematologic malignancies and solid tumors. Study Design: The study is an Institutional Review Board-approved, multicenter, double-blinded trial with 202 clinical research subjects analyzed in a total of 331 sample runs. All samples had been previously tested with traditional methods like karyotyping, fluorescence in situ hybridization and chromosomal microarray. The samples were from cases with a genetic diagnosis, cases without a genetic diagnosis and controls. Key Findings: This publication describes OGM performance metrics like first pass success rate and reproducibility from site-to-site, operator-to-operator and run-to-run for the first time ever and for the largest number of samples investigated with OGM to date. Key findings for the technical endpoints were reported as follows: Concordance with SOC - 97.7%; Partially concordant with SOC - 2.3%; Concordance with SOC for pathogenic variant calls - 100%; Concordance with CMA - 100%; First-pass success rate for OGM - 94%; Reproducibility of analytical QC from site-to-site - 98.8%; and Reproducibility of pathogenic variant calls from site-to-site - 100%. Key Takeaways: The authors concluded that a single approach, like OGM, can allow genetic laboratories to provide rapid results with a cost-effective solution, which can benefit both the lab and the affected individuals.

ShowHide Related Items >><<
BNGO Bionano Genomics
$2.73 /

-0.03 (-1.09%)

BNGO Bionano Genomics
$2.73 /

-0.03 (-1.09%)

12/27/21 Oppenheimer
Oppenheimer bullish on Bionano Genomics, sees potential Q4 upside
06/16/21 BTIG
Bionano Genomics initiated with a Buy at BTIG
02/08/21 Oppenheimer
Bionano Genomics price target raised to $15 from $1.50 at Oppenheimer
01/26/21 Ladenburg
Bionano Genomics price target raised to $14 from $1.25 at Ladenburg
BNGO Bionano Genomics
$2.73 /

-0.03 (-1.09%)

  • 20
    Jan
BNGO Bionano Genomics
$2.73 /

-0.03 (-1.09%)

Hot Stocks
Bionano Genomics announces prototype for next single molecule imaging system » 08:06
12/29/21
12/29
08:06
12/29/21
08:06
BNGO

Bionano Genomics

$3.07 /

-0.28 (-8.36%)

Bionano Genomics…

Bionano Genomics announced that it has completed the first prototype for its next single molecule imaging system for OGM. The prototype is being used to integrate and test the key engineering designs of a new instrument and consumable intended to meet the needs of high volume users. The commercial system based on this prototype is expected to be released in the first half of 2023. The company said, "We believe OGM provides the most comprehensive, reliable and cost-effective solution for detecting structural variations. OGM is a workflow comprised of four proprietary stages: ultra-high molecular weight DNA isolation; sequence-specific DNA labeling; single molecule linearization & imaging; and data processing and analysis. The third stage creates the molecule images and sequence motif patterns that are used to reveal SVs. This stage also sets the limit on the number of samples that can be processed per day. The throughput of the current Saphyr system is designed for the volumes encountered by academic medical centers doing standard clinical research in genomics, but large reference laboratories and contract research organizations with higher volumes require an instrument with higher throughput capabilities. Compared to the Saphyr system, which images DNA at a rate of approximately 205 Gbp per hour, the new system is expected to image nearly 820 Gbp per hour. The new instrument is designed to be configurable into an array of up to four instruments processing samples in parallel approximately six months after initial release. Other anticipated features of the new system include a new consumable design, higher capacity carousel for staging samples to be imaged and updated optical components all in a space-efficient benchtop footprint. The new imaging system will also incorporate features designed to make high throughput workflows more flexible, allowing for data collection to start without needing to wait for multiple samples being available, enabling high-coverage cancer experiments to be run next to lower coverage constitutional experiments and the ability to prioritize samples to be run ahead of all others. This flexibility is expected to surpass that of peer sequencing systems, where getting this flexibility often means waiting for enough samples to fill a flow cell or paying a significant per sample premium to have a sample consume more of a consumable. Prototype photos of the next single molecule imaging system for OGM will be made available on Bionano's social media channels on December 31, 2021."

ShowHide Related Items >><<
BNGO Bionano Genomics
$3.07 /

-0.28 (-8.36%)

BNGO Bionano Genomics
$3.07 /

-0.28 (-8.36%)

12/27/21 Oppenheimer
Oppenheimer bullish on Bionano Genomics, sees potential Q4 upside
06/16/21 BTIG
Bionano Genomics initiated with a Buy at BTIG
02/08/21 Oppenheimer
Bionano Genomics price target raised to $15 from $1.50 at Oppenheimer
01/26/21 Ladenburg
Bionano Genomics price target raised to $14 from $1.25 at Ladenburg
BNGO Bionano Genomics
$3.07 /

-0.28 (-8.36%)

  • 20
    Jan
  • 08
    Jan
BNGO Bionano Genomics
$3.07 /

-0.28 (-8.36%)

Recommendations
Oppenheimer bullish on Bionano Genomics, sees potential Q4 upside » 08:06
12/27/21
12/27
08:06
12/27/21
08:06
BNGO

Bionano Genomics

$3.24 /

-0.03 (-0.92%)

Oppenheimer analyst Kevin…

Oppenheimer analyst Kevin DeGeeter notes that Bionano Genomics is on track to meet or exceed its 2021 Saphyr placement goal of 150-plus. Multiple clinical validation studies to support reimbursement are enrolling well and commercial adoption is leading to higher consumable pull-through that should impact Q4 and 2022, he adds. On the last point, DeGeeter spoke to management regarding disclosure late last week regarding accreditation of University Hospitals Leuven in Belgium, which should drive uptick in consumables beginning in Q4. Bionano noted Leuven is one of several European labs completing accreditation with each high-volume lab expected to process 300-500 samples annually at $400-$500 per sample. The analyst has an Outperform rating and a price target of $14 on the shares.

ShowHide Related Items >><<
BNGO Bionano Genomics
$3.24 /

-0.03 (-0.92%)

BNGO Bionano Genomics
$3.24 /

-0.03 (-0.92%)

06/16/21 BTIG
Bionano Genomics initiated with a Buy at BTIG
02/08/21 Oppenheimer
Bionano Genomics price target raised to $15 from $1.50 at Oppenheimer
01/26/21 Ladenburg
Bionano Genomics price target raised to $14 from $1.25 at Ladenburg
01/22/21 Maxim
Bionano Genomics price target raised to $14 from $2 at Maxim
BNGO Bionano Genomics
$3.24 /

-0.03 (-0.92%)

  • 20
    Jan
  • 08
    Jan
BNGO Bionano Genomics
$3.24 /

-0.03 (-0.92%)

Over a month ago
Hot Stocks
Bionano says University Hospitals Leuven expand BELAC-accredited menu » 08:08
12/23/21
12/23
08:08
12/23/21
08:08
BNGO

Bionano Genomics

$3.27 /

-0.03 (-0.91%)

Bionano Genomics…

Bionano Genomics announced that University Hospitals Leuven in Belgium, after previously receiving its accreditation from the Belgian Accreditation Body for using OGM in analysis of acute lymphoblastic leukemia, is expanding its BELAC-accredited menu to include acute myeloid leukemia, chronic lymphocytic leukemia and facioscapulohumeral muscular dystrophy. "With the flexibility we now have as an accredited laboratory by BELAC, our teams can develop OGM-based assays addressing hematological malignancies without the need for a new audit," said Barbara Dewaele, PhD, supervisor of the Laboratory for Genetics of Malignant Disorders at University Hospitals Leuven. "We are excited to move forward using this valuable tool to analyze the genomes of patients with cancer and rare diseases." At the European Cytogenomics Conference in July 2021, Dr. Dewaele shared the results of implementing an OGM-based assay for ALL patients that her team developed with Bionano's Saphyr system. As presented by Dr. Dewaele and her team, compared to their existing workflow, the new workflow including OGM as a primary analysis method reduced the number of fluorescence in-situ hybridization probes used by 90% and eliminated the need for multiplexed ligation polymorphism assays. In their new workflow including OGM, it is complemented with karyotyping to detect ploidy changes and the presence of small subclones. This transformation resulted in a turnaround time that was 14 days faster, a cost savings of approximately 50% and higher overall success rates in finding pathogenic variants in samples. In parallel, as part of their menu expansion efforts, and under the direction of Dr. Valerie Race, Center for Human Genetics at University Hospitals Leuven, a validation of Bionano's EnFocus FSHD tool will be conducted on a prospective cohort of FSHD samples to confirm OGM's capability to accurately measure the length of D4Z4 repeat arrays and assess reproducibility and repeatability of the workflow. Preliminary results were presented at the European Society of Human Genetics conference in August 2021, and reported that OGM can be a powerful and robust technique for FSHD testing in genetic diagnostic laboratories by providing results that are concordant with the current gold standard, Southern blot analysis in a substantially simpler workflow that does not use radioactivity. Dr. Dewaele reported that she and her colleagues have doubled their weekly sample volume relative to when they first started using their Saphyr system and believe they are on track to reach their goal of 500 samples per year with this instrument. The teams at University Hospitals Leuven believe that the time and cost savings from using OGM-based assays could be a competitive advantage relative to traditional techniques. OGM is also complementary to many of the tools used in typical molecular pathology and cytogenomics labs and, as a result, it can be helpful to interpretation of results from assays such as karyotyping, which can be used to confirm OGM findings.

ShowHide Related Items >><<
BNGO Bionano Genomics
$3.27 /

-0.03 (-0.91%)

BNGO Bionano Genomics
$3.27 /

-0.03 (-0.91%)

06/16/21 BTIG
Bionano Genomics initiated with a Buy at BTIG
02/08/21 Oppenheimer
Bionano Genomics price target raised to $15 from $1.50 at Oppenheimer
01/26/21 Ladenburg
Bionano Genomics price target raised to $14 from $1.25 at Ladenburg
01/22/21 Maxim
Bionano Genomics price target raised to $14 from $2 at Maxim
BNGO Bionano Genomics
$3.27 /

-0.03 (-0.91%)

  • 20
    Jan
  • 08
    Jan
BNGO Bionano Genomics
$3.27 /

-0.03 (-0.91%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.